Advanced Proteome Therapeutics Announces Appointment of New Board members... Impressive.... This should have been done in one release....
Appointment of New Board Members
2018-04-16 17:04 ET - News Release
VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointments of Dr. John R. Garrett and Paul Woodward to its Board of Directors.
Dr. Garrett is a Principal of John Garrett & Partners with a practice focusing on early stage US and international biomedical companies as well as corporate initiatives in the domains of software, and communication companies. Since 2004, Dr. Garrett has led five startup companies in CEO/COO positions, including initiatives with partners emanating from Harvard University and Roswell Park Cancer Center. Currently, he is co-CEO of Glycosyn, Inc., centered on treating/curing common childhood diseases, and the Executive Director of Glycosyn Health Initiatives, devoted to bringing life-saving treatments to children in the developing world.
Paul Woodward is currently President of Conation Capital Corp., and has been a frequent investor in early stage private companies. Paul is a former investment banker with over 30 years of experience in venture markets.
Allen Krantz, COO/CSO of the Company, commented that “APC is extremely fortunate to have John’s highly skilled services with his great depth of business experience in growing companies, interpersonal skills, and technological grasp. Paul Woodward has been a strong supporter of APC. His extensive experience in capital markets and corporate finance will be a major asset to the Company going forward.”